| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Profiling | 46 | 2019 | 5149 | 3.170 |
Why?
|
| Gene Regulatory Networks | 20 | 2018 | 680 | 2.720 |
Why?
|
| Computational Biology | 18 | 2019 | 1291 | 2.520 |
Why?
|
| Transcription Factors | 35 | 2017 | 5438 | 2.230 |
Why?
|
| E2F4 Transcription Factor | 4 | 2017 | 30 | 2.100 |
Why?
|
| Transcriptome | 13 | 2018 | 1963 | 1.650 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2011 | 2471 | 1.620 |
Why?
|
| Gene Expression Regulation, Neoplastic | 21 | 2020 | 9042 | 1.490 |
Why?
|
| Breast Neoplasms | 22 | 2019 | 16215 | 1.450 |
Why?
|
| Molecular Sequence Annotation | 9 | 2017 | 198 | 1.380 |
Why?
|
| Saccharomyces cerevisiae | 10 | 2018 | 662 | 1.370 |
Why?
|
| Chromatin Immunoprecipitation | 13 | 2017 | 507 | 1.330 |
Why?
|
| Gene Expression Regulation | 20 | 2017 | 4130 | 1.320 |
Why?
|
| Genomics | 12 | 2020 | 2835 | 1.320 |
Why?
|
| Gene Expression Regulation, Fungal | 8 | 2017 | 107 | 1.220 |
Why?
|
| Tumor Microenvironment | 8 | 2020 | 3035 | 1.110 |
Why?
|
| Gene Expression | 9 | 2018 | 3640 | 1.080 |
Why?
|
| Genome, Human | 13 | 2018 | 1888 | 1.040 |
Why?
|
| Algorithms | 21 | 2019 | 3891 | 1.030 |
Why?
|
| Hematopoiesis | 4 | 2016 | 602 | 0.990 |
Why?
|
| Caenorhabditis elegans | 9 | 2016 | 280 | 0.990 |
Why?
|
| DNA Methylation | 8 | 2019 | 2765 | 0.980 |
Why?
|
| RNA, Untranslated | 7 | 2014 | 242 | 0.940 |
Why?
|
| Chromatin | 11 | 2014 | 1046 | 0.930 |
Why?
|
| MicroRNAs | 10 | 2016 | 2887 | 0.910 |
Why?
|
| Models, Genetic | 12 | 2016 | 1163 | 0.910 |
Why?
|
| Transcription, Genetic | 13 | 2017 | 3339 | 0.900 |
Why?
|
| CpG Islands | 7 | 2019 | 671 | 0.870 |
Why?
|
| STAT3 Transcription Factor | 3 | 2019 | 1136 | 0.860 |
Why?
|
| Histones | 8 | 2014 | 1513 | 0.850 |
Why?
|
| Data Mining | 2 | 2014 | 83 | 0.820 |
Why?
|
| Sequence Analysis, RNA | 9 | 2019 | 676 | 0.810 |
Why?
|
| Biomarkers, Tumor | 10 | 2020 | 10708 | 0.770 |
Why?
|
| Binding Sites | 15 | 2016 | 2255 | 0.740 |
Why?
|
| Databases, Genetic | 8 | 2017 | 757 | 0.730 |
Why?
|
| Databases, Nucleic Acid | 4 | 2018 | 116 | 0.710 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2012 | 257 | 0.690 |
Why?
|
| Sequence Analysis, DNA | 11 | 2017 | 2573 | 0.690 |
Why?
|
| Galectin 3 | 3 | 2016 | 131 | 0.660 |
Why?
|
| Endometriosis | 3 | 2017 | 231 | 0.640 |
Why?
|
| Evolution, Molecular | 8 | 2016 | 867 | 0.630 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2018 | 470 | 0.610 |
Why?
|
| E2F1 Transcription Factor | 2 | 2016 | 199 | 0.610 |
Why?
|
| Prognosis | 19 | 2020 | 22505 | 0.610 |
Why?
|
| B7 Antigens | 4 | 2020 | 84 | 0.610 |
Why?
|
| Cytogenetic Analysis | 1 | 2019 | 574 | 0.600 |
Why?
|
| Recombinational DNA Repair | 1 | 2017 | 79 | 0.580 |
Why?
|
| Genome | 3 | 2019 | 690 | 0.560 |
Why?
|
| Humans | 101 | 2020 | 270740 | 0.550 |
Why?
|
| Cell Cycle | 4 | 2013 | 2137 | 0.550 |
Why?
|
| Cell Cycle Checkpoints | 3 | 2018 | 271 | 0.540 |
Why?
|
| Leukocytes | 1 | 2018 | 421 | 0.530 |
Why?
|
| Encyclopedias as Topic | 2 | 2012 | 7 | 0.530 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2016 | 142 | 0.520 |
Why?
|
| Genes, Neoplasm | 2 | 2017 | 314 | 0.520 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 151 | 0.500 |
Why?
|
| Base Sequence | 18 | 2019 | 5437 | 0.500 |
Why?
|
| Receptors, Estrogen | 7 | 2019 | 2170 | 0.490 |
Why?
|
| Mycobacterium bovis | 1 | 2015 | 68 | 0.480 |
Why?
|
| User-Computer Interface | 1 | 2016 | 264 | 0.480 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 345 | 0.480 |
Why?
|
| Infertility | 1 | 2016 | 105 | 0.480 |
Why?
|
| Promoter Regions, Genetic | 10 | 2019 | 3216 | 0.470 |
Why?
|
| Survival Analysis | 11 | 2019 | 9292 | 0.470 |
Why?
|
| Genome, Fungal | 2 | 2011 | 56 | 0.460 |
Why?
|
| Models, Statistical | 5 | 2012 | 1184 | 0.460 |
Why?
|
| Cell Communication | 1 | 2017 | 512 | 0.460 |
Why?
|
| Macrophages | 2 | 2018 | 1350 | 0.450 |
Why?
|
| Neuroblastoma | 1 | 2019 | 705 | 0.450 |
Why?
|
| Computer Simulation | 4 | 2016 | 1570 | 0.450 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2016 | 236 | 0.450 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 417 | 0.450 |
Why?
|
| Oxidative Stress | 4 | 2016 | 1149 | 0.440 |
Why?
|
| Liposarcoma | 1 | 2016 | 248 | 0.440 |
Why?
|
| Conserved Sequence | 7 | 2014 | 498 | 0.430 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 1441 | 0.430 |
Why?
|
| Estrogen Receptor alpha | 3 | 2015 | 692 | 0.420 |
Why?
|
| Animals | 41 | 2020 | 61956 | 0.420 |
Why?
|
| Adenocarcinoma | 4 | 2019 | 7914 | 0.420 |
Why?
|
| Software | 3 | 2016 | 1355 | 0.410 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 5101 | 0.400 |
Why?
|
| RNA Interference | 1 | 2016 | 1388 | 0.400 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2016 | 2359 | 0.380 |
Why?
|
| Neoplasms | 8 | 2020 | 15927 | 0.380 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2019 | 7265 | 0.380 |
Why?
|
| Homeostasis | 1 | 2016 | 925 | 0.380 |
Why?
|
| Amino Acid Motifs | 5 | 2015 | 399 | 0.380 |
Why?
|
| RNA, Messenger | 13 | 2016 | 6390 | 0.370 |
Why?
|
| Transcription Initiation Site | 5 | 2014 | 48 | 0.370 |
Why?
|
| Cell Proliferation | 11 | 2019 | 7238 | 0.370 |
Why?
|
| Cell Line, Tumor | 14 | 2019 | 14849 | 0.370 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 824 | 0.370 |
Why?
|
| Disease Progression | 4 | 2019 | 6867 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2017 | 3658 | 0.360 |
Why?
|
| Protein Binding | 9 | 2015 | 3485 | 0.360 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 1105 | 0.350 |
Why?
|
| Internet | 4 | 2016 | 690 | 0.340 |
Why?
|
| 3' Untranslated Regions | 2 | 2019 | 339 | 0.340 |
Why?
|
| DNA Copy Number Variations | 4 | 2020 | 1568 | 0.330 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 278 | 0.330 |
Why?
|
| Female | 40 | 2019 | 148940 | 0.330 |
Why?
|
| Cluster Analysis | 6 | 2015 | 1075 | 0.330 |
Why?
|
| Signal Transduction | 13 | 2018 | 12103 | 0.320 |
Why?
|
| Organ Specificity | 7 | 2016 | 737 | 0.320 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 3949 | 0.310 |
Why?
|
| Leukemia | 2 | 2016 | 1719 | 0.310 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 2115 | 0.310 |
Why?
|
| Phosphorylation | 2 | 2015 | 4942 | 0.290 |
Why?
|
| Skin Neoplasms | 3 | 2018 | 4895 | 0.290 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2019 | 6256 | 0.290 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 14617 | 0.290 |
Why?
|
| DNA | 2 | 2012 | 3050 | 0.280 |
Why?
|
| Progesterone | 3 | 2017 | 711 | 0.280 |
Why?
|
| Melanoma | 3 | 2018 | 5595 | 0.280 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 12033 | 0.280 |
Why?
|
| DNA, Complementary | 6 | 2003 | 938 | 0.270 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2016 | 1840 | 0.270 |
Why?
|
| Fungal Proteins | 3 | 2017 | 271 | 0.270 |
Why?
|
| Endometrium | 3 | 2017 | 457 | 0.270 |
Why?
|
| Longevity | 1 | 2007 | 155 | 0.260 |
Why?
|
| HL-60 Cells | 2 | 2016 | 318 | 0.260 |
Why?
|
| Mice | 20 | 2020 | 35600 | 0.260 |
Why?
|
| Hypoxia | 2 | 2019 | 472 | 0.250 |
Why?
|
| Aspergillus fumigatus | 2 | 2017 | 136 | 0.250 |
Why?
|
| Genome-Wide Association Study | 5 | 2018 | 2351 | 0.250 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 6685 | 0.250 |
Why?
|
| Survival Rate | 7 | 2020 | 12541 | 0.240 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2016 | 319 | 0.240 |
Why?
|
| Mutation | 8 | 2018 | 15912 | 0.240 |
Why?
|
| BRCA1 Protein | 2 | 2019 | 528 | 0.230 |
Why?
|
| Drosophila melanogaster | 4 | 2014 | 866 | 0.230 |
Why?
|
| Biomarkers | 1 | 2016 | 5051 | 0.230 |
Why?
|
| Immunotherapy | 4 | 2020 | 3557 | 0.230 |
Why?
|
| RNA-Binding Proteins | 5 | 2017 | 1017 | 0.230 |
Why?
|
| Models, Biological | 7 | 2018 | 3194 | 0.220 |
Why?
|
| Drug Discovery | 2 | 2016 | 329 | 0.220 |
Why?
|
| Genes, cdc | 2 | 2013 | 84 | 0.220 |
Why?
|
| Ribosomes | 3 | 2015 | 168 | 0.220 |
Why?
|
| Carcinoma | 1 | 2014 | 2610 | 0.220 |
Why?
|
| Glioblastoma | 3 | 2019 | 1776 | 0.210 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 1032 | 0.210 |
Why?
|
| HeLa Cells | 4 | 2016 | 1685 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5593 | 0.210 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2431 | 0.200 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2928 | 0.200 |
Why?
|
| Nucleotide Motifs | 4 | 2017 | 61 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5257 | 0.200 |
Why?
|
| Yeasts | 2 | 2015 | 76 | 0.200 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2014 | 204 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 2 | 2017 | 38 | 0.180 |
Why?
|
| Artificial Intelligence | 3 | 2014 | 425 | 0.180 |
Why?
|
| Cell Line | 6 | 2017 | 5338 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 1456 | 0.180 |
Why?
|
| Estrogens | 2 | 2016 | 805 | 0.180 |
Why?
|
| Case-Control Studies | 5 | 2019 | 6224 | 0.180 |
Why?
|
| Genes, Fungal | 3 | 2014 | 94 | 0.180 |
Why?
|
| Peripheral Tolerance | 1 | 2020 | 4 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 10400 | 0.180 |
Why?
|
| Estradiol | 2 | 2016 | 827 | 0.180 |
Why?
|
| Chromones | 2 | 2017 | 121 | 0.170 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 4958 | 0.170 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 5002 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2018 | 1655 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 396 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5408 | 0.170 |
Why?
|
| CD36 Antigens | 1 | 2019 | 50 | 0.170 |
Why?
|
| Apoptosis | 9 | 2019 | 7757 | 0.170 |
Why?
|
| Schizosaccharomyces | 2 | 2018 | 118 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2015 | 1367 | 0.170 |
Why?
|
| Neoadjuvant Therapy | 3 | 2017 | 5231 | 0.160 |
Why?
|
| Support Vector Machine | 1 | 2019 | 41 | 0.160 |
Why?
|
| Cloning, Molecular | 9 | 2003 | 1430 | 0.160 |
Why?
|
| Huntingtin Protein | 1 | 2018 | 61 | 0.150 |
Why?
|
| Morpholines | 2 | 2017 | 296 | 0.150 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2018 | 103 | 0.150 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2019 | 191 | 0.150 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 103 | 0.150 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2018 | 84 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 2454 | 0.150 |
Why?
|
| Chromosomal Instability | 1 | 2019 | 229 | 0.150 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 2453 | 0.150 |
Why?
|
| Species Specificity | 4 | 2014 | 794 | 0.150 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2018 | 197 | 0.150 |
Why?
|
| Centromere Protein B | 1 | 2017 | 8 | 0.150 |
Why?
|
| MCF-7 Cells | 2 | 2016 | 547 | 0.150 |
Why?
|
| Catabolite Repression | 1 | 2017 | 1 | 0.150 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2018 | 154 | 0.150 |
Why?
|
| Lentivirus | 1 | 2018 | 164 | 0.140 |
Why?
|
| Epigenomics | 1 | 2019 | 273 | 0.140 |
Why?
|
| GATA1 Transcription Factor | 2 | 2014 | 17 | 0.140 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 491 | 0.140 |
Why?
|
| Exons | 5 | 2012 | 1383 | 0.140 |
Why?
|
| Protein Interaction Mapping | 3 | 2015 | 168 | 0.140 |
Why?
|
| Data Curation | 1 | 2017 | 12 | 0.140 |
Why?
|
| Lymphokines | 1 | 2018 | 313 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 2 | 2017 | 444 | 0.140 |
Why?
|
| RNA Caps | 1 | 2016 | 40 | 0.140 |
Why?
|
| Sequence Alignment | 3 | 2008 | 876 | 0.140 |
Why?
|
| Genetic Pleiotropy | 1 | 2016 | 29 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2018 | 2422 | 0.140 |
Why?
|
| Immune System | 1 | 2018 | 275 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2019 | 440 | 0.140 |
Why?
|
| Cation Transport Proteins | 2 | 2016 | 170 | 0.140 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 110 | 0.140 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 367 | 0.140 |
Why?
|
| Neuropeptides | 1 | 2017 | 167 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 153 | 0.130 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2016 | 20 | 0.130 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 125 | 0.130 |
Why?
|
| Carbon | 1 | 2017 | 165 | 0.130 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 220 | 0.130 |
Why?
|
| Computer-Aided Design | 1 | 2016 | 76 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2016 | 77 | 0.130 |
Why?
|
| Androstadienes | 1 | 2016 | 172 | 0.130 |
Why?
|
| Molecular Docking Simulation | 1 | 2016 | 163 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2020 | 1137 | 0.130 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2015 | 34 | 0.130 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2016 | 71 | 0.130 |
Why?
|
| Glioma | 2 | 2017 | 1978 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 506 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 275 | 0.130 |
Why?
|
| Methyltransferases | 1 | 2016 | 152 | 0.130 |
Why?
|
| Programming Languages | 1 | 2015 | 21 | 0.130 |
Why?
|
| Genes, Regulator | 1 | 2015 | 81 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 5759 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 1199 | 0.120 |
Why?
|
| Logistic Models | 2 | 2015 | 3444 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2014 | 3 | 0.120 |
Why?
|
| Neurospora crassa | 1 | 2014 | 7 | 0.120 |
Why?
|
| Aspergillosis | 1 | 2017 | 248 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 1710 | 0.120 |
Why?
|
| Terminator Regions, Genetic | 1 | 2014 | 9 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 557 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 497 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 350 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 522 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1111 | 0.120 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 10265 | 0.120 |
Why?
|
| SEER Program | 1 | 2018 | 1047 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 195 | 0.120 |
Why?
|
| Phosphoproteins | 2 | 2017 | 1138 | 0.120 |
Why?
|
| Drug Design | 1 | 2016 | 372 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2013 | 4644 | 0.120 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 327 | 0.120 |
Why?
|
| Circadian Clocks | 1 | 2014 | 63 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2014 | 460 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2017 | 1503 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2014 | 65 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 1189 | 0.110 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 247 | 0.110 |
Why?
|
| E2F Transcription Factors | 1 | 2013 | 137 | 0.110 |
Why?
|
| ROC Curve | 1 | 2017 | 1248 | 0.110 |
Why?
|
| Acetophenones | 1 | 2013 | 23 | 0.110 |
Why?
|
| Mitosis | 1 | 2016 | 681 | 0.110 |
Why?
|
| Protein Biosynthesis | 2 | 2015 | 1028 | 0.110 |
Why?
|
| Tissue Distribution | 4 | 2002 | 927 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2016 | 521 | 0.110 |
Why?
|
| Receptors, GABA-A | 1 | 2013 | 81 | 0.110 |
Why?
|
| Proteins | 2 | 2012 | 2043 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 617 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2015 | 729 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 204 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2016 | 742 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2016 | 3584 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2017 | 1140 | 0.110 |
Why?
|
| Diploidy | 1 | 2013 | 116 | 0.110 |
Why?
|
| Time Factors | 6 | 2013 | 13006 | 0.110 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2014 | 162 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2018 | 1101 | 0.110 |
Why?
|
| DNA Footprinting | 1 | 2012 | 36 | 0.110 |
Why?
|
| Deoxyribonuclease I | 1 | 2012 | 84 | 0.100 |
Why?
|
| beta Catenin | 1 | 2016 | 683 | 0.100 |
Why?
|
| Base Composition | 1 | 2012 | 93 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 5776 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1542 | 0.100 |
Why?
|
| Cytokines | 2 | 2018 | 2825 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2019 | 4329 | 0.100 |
Why?
|
| Sirolimus | 1 | 2016 | 831 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2016 | 825 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 661 | 0.100 |
Why?
|
| STAT4 Transcription Factor | 1 | 2011 | 13 | 0.100 |
Why?
|
| K562 Cells | 3 | 2019 | 344 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 840 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2003 | 1082 | 0.100 |
Why?
|
| Gene Components | 1 | 2011 | 15 | 0.100 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 1097 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2016 | 1875 | 0.090 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 288 | 0.090 |
Why?
|
| Amino Acid Sequence | 9 | 2003 | 4567 | 0.090 |
Why?
|
| Breast | 2 | 2019 | 1369 | 0.090 |
Why?
|
| Genome, Helminth | 1 | 2010 | 10 | 0.090 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 1089 | 0.090 |
Why?
|
| Chorionic Gonadotropin | 1 | 2011 | 127 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 906 | 0.090 |
Why?
|
| Mammals | 1 | 2012 | 369 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 1063 | 0.090 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2010 | 82 | 0.090 |
Why?
|
| Genome, Insect | 1 | 2011 | 104 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 332 | 0.090 |
Why?
|
| Acetylation | 1 | 2011 | 515 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2002 | 203 | 0.090 |
Why?
|
| Systems Biology | 1 | 2010 | 115 | 0.090 |
Why?
|
| Pseudogenes | 1 | 2010 | 91 | 0.090 |
Why?
|
| DNA Repair | 2 | 2016 | 1909 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 979 | 0.090 |
Why?
|
| Trophoblasts | 1 | 2011 | 152 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 1563 | 0.090 |
Why?
|
| Male | 12 | 2018 | 128315 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2017 | 2250 | 0.090 |
Why?
|
| Chromosomes | 1 | 2010 | 325 | 0.080 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2009 | 10 | 0.080 |
Why?
|
| Protein Interaction Maps | 3 | 2016 | 151 | 0.080 |
Why?
|
| Quality Control | 1 | 2011 | 461 | 0.080 |
Why?
|
| Lymphocyte Activation | 3 | 2020 | 1723 | 0.080 |
Why?
|
| Receptor, ErbB-2 | 1 | 2019 | 2651 | 0.080 |
Why?
|
| Argonaute Proteins | 1 | 2009 | 42 | 0.080 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2009 | 67 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 4000 | 0.080 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 4795 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 1958 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 1109 | 0.080 |
Why?
|
| Sarcomeres | 1 | 2009 | 34 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2069 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 95 | 0.080 |
Why?
|
| Alleles | 2 | 2012 | 2600 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 763 | 0.080 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 1386 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 2 | 2015 | 78 | 0.080 |
Why?
|
| Proteomics | 1 | 2016 | 1427 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 617 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2015 | 1305 | 0.080 |
Why?
|
| Ribonuclease III | 1 | 2009 | 182 | 0.080 |
Why?
|
| DNA Probes | 1 | 2008 | 247 | 0.080 |
Why?
|
| Histone Deacetylases | 2 | 2011 | 364 | 0.070 |
Why?
|
| Free Radicals | 1 | 2007 | 64 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 4481 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2016 | 5694 | 0.070 |
Why?
|
| Receptors, Steroid | 1 | 2009 | 337 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2399 | 0.070 |
Why?
|
| Caloric Restriction | 1 | 2007 | 88 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 896 | 0.070 |
Why?
|
| Cytosol | 1 | 2007 | 267 | 0.070 |
Why?
|
| Primary Cell Culture | 2 | 2017 | 199 | 0.070 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2018 | 274 | 0.070 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 240 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 5315 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 1903 | 0.070 |
Why?
|
| Phenotype | 2 | 2018 | 6509 | 0.070 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2005 | 9 | 0.070 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3345 | 0.070 |
Why?
|
| Pongo pygmaeus | 1 | 2005 | 8 | 0.070 |
Why?
|
| Actins | 1 | 2009 | 602 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 3438 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 6177 | 0.070 |
Why?
|
| Zebrafish | 1 | 2009 | 457 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2018 | 33737 | 0.060 |
Why?
|
| Sirtuins | 1 | 2005 | 43 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2005 | 154 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2019 | 2090 | 0.060 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 628 | 0.060 |
Why?
|
| Brain | 3 | 2005 | 4208 | 0.060 |
Why?
|
| Tacrolimus | 1 | 2006 | 347 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 3597 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2012 | 2166 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2005 | 221 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 2617 | 0.060 |
Why?
|
| Testis | 3 | 2001 | 620 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 3707 | 0.060 |
Why?
|
| ras Proteins | 1 | 2007 | 804 | 0.050 |
Why?
|
| Chromosome Mapping | 3 | 2002 | 1655 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 483 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2015 | 307 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 1472 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2015 | 157 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2002 | 46 | 0.050 |
Why?
|
| Microtubule Proteins | 1 | 2001 | 43 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 721 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1286 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 14012 | 0.050 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2001 | 20 | 0.050 |
Why?
|
| Cyclophilins | 1 | 2001 | 32 | 0.050 |
Why?
|
| United States | 1 | 2018 | 15861 | 0.050 |
Why?
|
| Introns | 4 | 2003 | 461 | 0.040 |
Why?
|
| Stress, Physiological | 2 | 2017 | 486 | 0.040 |
Why?
|
| Calcium | 1 | 2006 | 1578 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 2015 | 223 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2001 | 168 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 73333 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 7381 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2002 | 530 | 0.040 |
Why?
|
| Peptides | 3 | 2018 | 1504 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2003 | 678 | 0.040 |
Why?
|
| Reference Values | 2 | 2013 | 1133 | 0.040 |
Why?
|
| Cell Growth Processes | 1 | 2019 | 336 | 0.040 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2018 | 71 | 0.040 |
Why?
|
| Response Elements | 2 | 2009 | 192 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 178 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2018 | 71 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2018 | 39890 | 0.040 |
Why?
|
| Homologous Recombination | 1 | 2019 | 187 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 7100 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 135 | 0.040 |
Why?
|
| Microsatellite Instability | 1 | 2020 | 408 | 0.040 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 182 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2012 | 276 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 210 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2018 | 153 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2018 | 241 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2018 | 581 | 0.040 |
Why?
|
| Anemia | 1 | 2003 | 728 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2017 | 125 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2018 | 537 | 0.040 |
Why?
|
| Fetus | 1 | 2001 | 674 | 0.030 |
Why?
|
| Ovary | 1 | 2001 | 688 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2017 | 80 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2017 | 110 | 0.030 |
Why?
|
| Cell Movement | 2 | 2017 | 2472 | 0.030 |
Why?
|
| Heterografts | 1 | 2019 | 738 | 0.030 |
Why?
|
| Primates | 1 | 2016 | 128 | 0.030 |
Why?
|
| Adult | 4 | 2019 | 82040 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2017 | 564 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2018 | 420 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2018 | 589 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2016 | 188 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2019 | 9470 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 1012 | 0.030 |
Why?
|
| Unsupervised Machine Learning | 1 | 2015 | 20 | 0.030 |
Why?
|
| Epithelium | 1 | 2017 | 782 | 0.030 |
Why?
|
| Methylation | 1 | 2016 | 625 | 0.030 |
Why?
|
| Flavonoids | 1 | 2016 | 199 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 371 | 0.030 |
Why?
|
| Knowledge Bases | 1 | 2015 | 49 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 25 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 354 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 82 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 714 | 0.030 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 149 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 4147 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 1823 | 0.030 |
Why?
|
| Telomerase | 1 | 2017 | 547 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 189 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2013 | 42 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 15218 | 0.030 |
Why?
|
| Pyrazines | 1 | 2017 | 510 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 214 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 1826 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 77 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 1553 | 0.030 |
Why?
|
| Larva | 1 | 2014 | 293 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 317 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 387 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 2098 | 0.030 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2013 | 115 | 0.030 |
Why?
|
| Databases, Protein | 1 | 2013 | 101 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 754 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 736 | 0.030 |
Why?
|
| Quinolines | 1 | 2016 | 402 | 0.030 |
Why?
|
| PPAR delta | 1 | 2013 | 53 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2017 | 1691 | 0.030 |
Why?
|
| Protein Kinases | 2 | 2007 | 902 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2013 | 494 | 0.030 |
Why?
|
| Staurosporine | 1 | 2012 | 147 | 0.030 |
Why?
|
| Poly A | 1 | 2012 | 96 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 1075 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2014 | 433 | 0.030 |
Why?
|
| Multigene Family | 1 | 2013 | 469 | 0.020 |
Why?
|
| Thiazoles | 1 | 2016 | 723 | 0.020 |
Why?
|
| Pregnancy | 2 | 2002 | 8130 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2012 | 198 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2013 | 367 | 0.020 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2011 | 6 | 0.020 |
Why?
|
| Insulator Elements | 1 | 2011 | 7 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 561 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 3117 | 0.020 |
Why?
|
| Neurons | 1 | 2002 | 2439 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2010 | 8 | 0.020 |
Why?
|
| Genes, Helminth | 1 | 2010 | 26 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2010 | 22 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1483 | 0.020 |
Why?
|
| Carcinogenesis | 1 | 2017 | 1033 | 0.020 |
Why?
|
| Imidazoles | 1 | 2017 | 1065 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3917 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 1099 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1586 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2011 | 128 | 0.020 |
Why?
|
| Gene Library | 2 | 2001 | 353 | 0.020 |
Why?
|
| Stem Cells | 1 | 2017 | 1216 | 0.020 |
Why?
|
| Piperidines | 1 | 2016 | 1100 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 183 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 5728 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 4223 | 0.020 |
Why?
|
| Electron Transport | 1 | 2009 | 78 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 854 | 0.020 |
Why?
|
| Middle Aged | 4 | 2019 | 90352 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2009 | 94 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2009 | 92 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 1049 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 1002 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 134 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 1718 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 298 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2011 | 289 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 997 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 295 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 2311 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2010 | 623 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2010 | 442 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2009 | 271 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2009 | 155 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 501 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2010 | 1028 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 379 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 143 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 3063 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2007 | 378 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 2657 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2010 | 799 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 2220 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 538 | 0.020 |
Why?
|
| Vitamin K 3 | 1 | 2005 | 6 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2005 | 18 | 0.020 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2005 | 34 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1076 | 0.020 |
Why?
|
| Adenylyl Cyclases | 1 | 2005 | 103 | 0.020 |
Why?
|
| Aging | 1 | 2013 | 1534 | 0.020 |
Why?
|
| Genotype | 1 | 2013 | 4252 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 9039 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 5056 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2005 | 289 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2175 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 5457 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 4961 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 272 | 0.010 |
Why?
|
| Receptors for Activated C Kinase | 1 | 2002 | 7 | 0.010 |
Why?
|
| Spermatids | 1 | 2001 | 38 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 175 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2002 | 78 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2010 | 2375 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 338 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 726 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 1474 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4821 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 1160 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 257 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2001 | 287 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2001 | 545 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 1697 | 0.010 |
Why?
|
| Phylogeny | 1 | 2001 | 867 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 668 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 3028 | 0.010 |
Why?
|
| Myocardium | 1 | 2001 | 1232 | 0.010 |
Why?
|
| Prostate | 1 | 2001 | 1089 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 1470 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 22251 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 30998 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 32767 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 6441 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 5866 | 0.000 |
Why?
|